Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NutropinAq for prevention of long-term glucocorticoid adverse effects in children with chronic disease
2004-001164-41Phase 2Terminated
- Sponsor
- Ipsen
- Start
- Sep 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of somatropin in adverse effect (2 arms), sponsored by Ipsen. Started Sep 2004; status: terminated.
02
Drugs
somatropin
03
Conditions
adverse effect
Beyond the preview
Go deeper on 2004-001164-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001164-41.